Pashtoon Kasi/LinkedIn
Jan 24, 2025, 13:02
Pashtoon Kasi: Impact of HER2 blockade with trastuzumab in addition to chemotherapy in resectable gastric cancer
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post on X:
“Impact of HER2 Negative blockade with trastuzumab +/- pertuzumab in addition to chemo in patients with resectable gastric cancer.
Not the same parallels as in breast cancer. No added benefit with patients getting FLOT.
Maybe trastuzumab if shrinkage required.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 10:44
May 29, 2025, 10:34
May 29, 2025, 10:24
May 29, 2025, 10:17
May 29, 2025, 09:25